The following is a news Item reported by Reuters: WASHINGTON, January 29 (Reuters) Orville Medical Group, a maker of reconstructive Implants for knees and hips, on Tuesday filed to sell 3 million shares of common stock. In a filling with the U.S. Securlties and Exchange Commission, It sald it plans to use the proceeds from the offering for general corporate purposes, working capltal, research and development, and acquisitions. After the sale there will be about 34.0 million shares outstanding In the Arlington, Tennessee-based company, according to the SEC filing. Orville shares closed at $17.40 on Nasdaq. The common stock of Orville Medical Group has a par of $0.02 per share. Requlred: Prepare the journal entry to record the sale of the shares assuming the price existing when the announcement was made and Ignoring share issue costs. Note: If no entry is requlred for a transaction/event, select "No journal entry requlred" In the first account fleld. Enter your answers In whole dollars and not In millions. Journal entry worksheet Note: Enter debits before credits